+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurostimulation Device Market - Global Forecast 2026-2032- Product Image
Neurostimulation Device Market - Global Forecast 2026-2032- Product Image
Sale

Neurostimulation Device Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968618
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurostimulation Device Market is projected to reach USD 8.26 Billion in 2026. It is expected to continue growing at a CAGR of 12.27%, reaching USD 16.64 Billion by 2032.

Neurostimulation devices are implantable or wearable technologies that modulate neural activity through targeted electrical pulses, supporting treatment pathways in chronic pain, Parkinson’s disease, epilepsy, essential tremor, depression, urinary and fecal incontinence, migraine, and other neurological or functional disorders. Demand is reinforced by a measurable clinical burden: the World Health Organization reports that neurological conditions affected more than 3 billion people globally in 2021, while epilepsy affects around 50 million people worldwide and Parkinson’s disease affects more than 10 million people globally.

The market is moving from device-centric therapy toward evidence-led neuromodulation ecosystems that combine implantable pulse generators, leads, external programmers, remote monitoring, patient engagement tools, and clinician decision support. Spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, responsive neurostimulation, and transcranial stimulation are increasingly assessed on durability of outcomes, safety profile, battery longevity, MRI compatibility, reimbursement support, cybersecurity, patient quality of life, and total cost of care.

Transformative Shifts in the Neurostimulation Landscape

The neurostimulation device landscape is being reshaped by miniaturized implants, rechargeable and longer-life batteries, directional leads, closed-loop sensing, high-frequency stimulation, burst stimulation, and less invasive placement techniques. These shifts are important because therapy adoption depends not only on clinical efficacy but also on procedural risk, device maintenance, patient comfort, programming efficiency, and long-term adherence.

A second transformation is the convergence of neuromodulation with digital health. Remote programming, cloud-connected follow-up, and patient-reported outcome capture are helping care teams optimize stimulation settings outside traditional clinic visits. At the same time, payers and health systems are demanding stronger real-world evidence, making registries, post-market surveillance, clinical outcomes tracking, and outcomes-based value narratives central to commercial success.

Cumulative Impact of Artificial Intelligence in Neurostimulation

Artificial intelligence is adding cumulative value across the neurostimulation lifecycle, from patient selection and surgical planning to adaptive stimulation, remote monitoring, and post-market evidence generation. AI-enabled analytics can help identify stimulation-response patterns, flag adverse trends, and support personalized programming, particularly in therapies where small changes in amplitude, pulse width, frequency, or contact configuration can meaningfully affect outcomes.

The near-term impact is strongest in decision support rather than fully autonomous therapy. Regulators such as the U.S. Food and Drug Administration continue to emphasize transparency, validation, cybersecurity, human oversight, and lifecycle management for AI/ML-enabled medical devices. For neurostimulation manufacturers, competitive advantage will depend on clinically validated algorithms, high-quality datasets, explainable outputs, human-in-the-loop workflows, secure device connectivity, and documented performance across diverse patient populations.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East & Africa

North America remains a leading region for neurostimulation adoption due to specialist infrastructure, established reimbursement pathways, active clinical research, and early uptake of spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and responsive neurostimulation. The United States anchors regional demand through advanced neurosurgery, pain management, and epilepsy care networks, while Canada benefits from publicly funded care pathways that emphasize evidence-based utilization and provincial health technology review.

Europe is shaped by strong clinical standards, national reimbursement review, and the European Union’s Medical Device Regulation, which raises expectations for clinical evidence, traceability, and post-market surveillance. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in neurology capacity, medical technology access, digital hospitals, and local manufacturing. Latin America is led by expanding private hospital networks and specialty centers in countries such as Brazil and Mexico, with access influenced by reimbursement variability and income disparities. The Middle East is advancing through tertiary care investment, medical tourism, and national health modernization programs, particularly in Gulf economies. Africa remains more selective, with adoption concentrated in major urban hospitals and private specialty centers, while limited trained specialists, device affordability, and follow-up infrastructure remain key barriers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7 & NATO

Within ASEAN, neurostimulation access is supported by rising specialty care investment in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, although availability varies widely between urban tertiary centers and rural systems. Demand is linked to growing neurology services, increasing private insurance penetration in selected countries, and medical travel for advanced procedures. GCC countries are prioritizing advanced hospital infrastructure, digital health, and specialty neurology services, creating opportunities for premium neurostimulation platforms in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman, particularly where government-backed health transformation programs are expanding tertiary care capacity.

The European Union is defined by rigorous regulatory oversight, coordinated health technology assessment momentum, and strong demand for proven long-term outcomes under the Medical Device Regulation. BRICS markets provide scale through large patient populations and expanding domestic medtech capabilities, led by China and India, while Brazil, Russia, and South Africa present more uneven access linked to reimbursement, procurement, and specialist distribution. G7 countries remain central to innovation, reimbursement evolution, clinical guideline development, and post-market evidence generation. NATO member markets benefit from mature healthcare procurement systems, high regulatory alignment across much of North America and Europe, and cross-border clinical collaboration that supports training, evidence exchange, and adoption of advanced neuromodulation technologies.

Key Country Insights Across Major Neurostimulation Markets

The United States is the most influential country market, supported by FDA-cleared neuromodulation platforms, high procedural capacity, broad pain management infrastructure, and substantial chronic pain and neurological disease burden; CDC data show chronic pain affects about one in five U.S. adults. Canada emphasizes evidence-based access and provincial coverage decisions, while Mexico is expanding private-sector demand in major cities and Brazil is strengthening specialty hospital capabilities across large metropolitan areas, despite reimbursement and access variation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature neurology, neurosurgery, and pain care networks with payer scrutiny and health technology assessment requirements, while Germany and France are especially important for evidence-led adoption in advanced implantable therapies. Russia presents demand driven by neurological burden but faces access, procurement, and supply complexity. China is scaling neurology infrastructure, domestic device production, and hospital modernization; India combines a large patient base with rising private healthcare investment and expanding neurosurgical capacity; Japan has strong adoption of advanced implantable technologies supported by aging-population needs and high clinical standards; Australia maintains structured clinical governance and reimbursement review; and South Korea offers sophisticated hospitals, strong digital health readiness, and high receptivity to connected medical technologies.

Actionable Recommendations for Neurostimulation Industry Leaders

Industry leaders should prioritize clinically differentiated indications, real-world evidence, and physician workflow integration. Organizations that demonstrate durable pain reduction, motor symptom improvement, seizure reduction, urinary symptom control, or functional gains with clear safety data will be better positioned in payer, procurement, and health technology assessment discussions.

Manufacturers should invest in closed-loop capabilities, MRI-compatible systems, rechargeable and low-maintenance platforms, cybersecurity, interoperability, and remote programming models. Commercial teams should also develop region-specific reimbursement strategies, expand clinician training, strengthen post-market surveillance, support patient education, and build partnerships with neurology, neurosurgery, pain management, rehabilitation, urology, psychiatry, and digital health stakeholders.

Research Methodology

This executive summary is built from a structured secondary-research approach using verified public and institutional sources, including regulatory databases, clinical guideline bodies, peer-reviewed medical literature, World Health Organization disease burden data, U.S. FDA device information, CDC chronic pain statistics, and recognized disease-focused organizations covering Parkinson’s disease, epilepsy, migraine, and other neurological conditions.

The analysis synthesizes technology trends, regional healthcare infrastructure, reimbursement dynamics, regulatory requirements, disease epidemiology, clinical adoption patterns, and competitive innovation signals without applying market sizing, market share, or forecasting assumptions. Findings are interpreted through a market strategy lens to identify adoption drivers, access barriers, evidence requirements, and commercialization priorities relevant to neurostimulation device manufacturers, investors, providers, and policy stakeholders.

Conclusion

The neurostimulation device market is entering a more personalized, connected, and evidence-intensive phase. Rising neurological and chronic pain burden, combined with advances in implant design, sensing, programming, remote care, and AI-supported analytics, is expanding the role of neuromodulation across both established and emerging indications.

Sustainable progress will depend on proven clinical outcomes, reimbursement alignment, regulatory readiness, cybersecurity, clinician training, and scalable care delivery. Stakeholders that combine strong device engineering with data-backed therapy optimization and market-specific access strategies will be best positioned to lead the next phase of neurostimulation innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurostimulation Device Market, by Product Type
7.1. Introduction
7.2. Cochlear Implants
7.3. Deep Brain Stimulators (DBS)
7.4. Sacral Nerve Stimulators (SNS)
7.5. Spinal Cord Stimulators (SCS)
7.6. Vagus Nerve Stimulators (VNS)
8. Neurostimulation Device Market, by Material Type
8.1. Introduction
8.2. Metallic Biomaterials
8.3. Polymeric Biomaterials
9. Neurostimulation Device Market, by Power Source
9.1. Introduction
9.2. Non-Rechargeable Neurostimulators
9.3. Rechargeable Neurostimulators
10. Neurostimulation Device Market, by Technology
10.1. Introduction
10.2. Implantable Neurostimulation Devices
10.3. Non-Implantable Devices
11. Neurostimulation Device Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Neurostimulation Device Market, by Application
12.1. Introduction
12.2. Gastrointestinal Disorders
12.3. Hearing Loss
12.4. Neurological Disorders
12.4.1. Dystonia
12.4.2. Epilepsy
12.4.3. Essential Tremor
12.4.4. Parkinson’s Disease
12.5. Pain Management
12.5.1. Cancer Pain
12.5.2. Chronic Pain
12.6. Sleep Apnea
12.7. Urinary & Fecal Incontinence
12.7.1. Bowel Disorders
12.7.2. Overactive Bladder
13. Neurostimulation Device Market, by End User
13.1. Introduction
13.2. Ambulatory Surgery Centers (ASCs)
13.3. Home Healthcare
13.4. Hospitals
13.5. Specialty Clinics
14. Neurostimulation Device Market, by Distribution Channel
14.1. Introduction
14.2. Offline
14.3. Online
15. Neurostimulation Device Market, by Region
15.1. Asia-Pacific
15.2. North America
15.3. Latin America
15.4. Europe
15.5. Middle East
15.6. Africa
16. Neurostimulation Device Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Neurostimulation Device Market, by Country
17.1. United States
17.2. Germany
17.3. China
17.4. United Kingdom
17.5. India
17.6. Japan
17.7. Russia
17.8. Brazil
17.9. Canada
17.10. Italy
17.11. Mexico
17.12. France
17.13. Spain
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Bayer AG
19.3. Beijing PINS Medical Co.
19.4. Bioventus Inc.
19.5. Boston Scientific Corporation
19.6. Cefaly Technology
19.7. Curonix LLC.
19.8. electroCore Inc
19.9. InCube Labs.
19.10. Integra LifeSciences Holdings Corporation
19.11. LivaNova PLC
19.12. Medtronic PLC
19.13. MicroTransponder, Inc.
19.14. Motif Neurotech, Inc.
19.15. Neurosigma, Inc.
19.16. Nevro Corporation
19.17. SceneRay Co., Ltd
19.18. Soterix Medical, Inc.
19.19. Stimwave LLC
19.20. Synapse Biomedical Inc.
List of Figures
FIGURE 1. GLOBAL NEUROSTIMULATION DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL COCHLEAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL COCHLEAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL COCHLEAR IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DEEP BRAIN STIMULATORS (DBS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DEEP BRAIN STIMULATORS (DBS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DEEP BRAIN STIMULATORS (DBS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SACRAL NERVE STIMULATORS (SNS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SACRAL NERVE STIMULATORS (SNS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SACRAL NERVE STIMULATORS (SNS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SPINAL CORD STIMULATORS (SCS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SPINAL CORD STIMULATORS (SCS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SPINAL CORD STIMULATORS (SCS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VAGUS NERVE STIMULATORS (VNS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL VAGUS NERVE STIMULATORS (VNS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL VAGUS NERVE STIMULATORS (VNS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL NON-RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL NON-RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NON-RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL RECHARGEABLE NEUROSTIMULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL IMPLANTABLE NEUROSTIMULATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL IMPLANTABLE NEUROSTIMULATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL IMPLANTABLE NEUROSTIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NON-IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NON-IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL NON-IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HEARING LOSS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HEARING LOSS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HEARING LOSS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DYSTONIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DYSTONIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DYSTONIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CANCER PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CANCER PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CANCER PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SLEEP APNEA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SLEEP APNEA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SLEEP APNEA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL URINARY & FECAL INCONTINENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL URINARY & FECAL INCONTINENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL URINARY & FECAL INCONTINENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BOWEL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BOWEL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BOWEL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL OVERACTIVE BLADDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL OVERACTIVE BLADDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL OVERACTIVE BLADDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL AMBULATORY SURGERY CENTERS (ASCS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY SURGERY CENTERS (ASCS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL AMBULATORY SURGERY CENTERS (ASCS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 154. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 155. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 156. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 158. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 159. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 160. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 177. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 178. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 180. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 182. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 183. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 184. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 190. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 191. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 192. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 193. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 195. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 196. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 197. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 199. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 202. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 203. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 205. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 206. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 207. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 208. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 209. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 226. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 227. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 229. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 231. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 232. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 233. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 235. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 238. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 239. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 241. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 243. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 244. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 245. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 250. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 251. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 253. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 255. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 256. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 257. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 275. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 276. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 277. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 278. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 280. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 281. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 282. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 287. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 288. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 289. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 290. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 291. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 292. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 293. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 294. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 302. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 308. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 311. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 312. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 313. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 314. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 316. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 317. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 318. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 320. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 323. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 324. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 326. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 327. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 328. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 329. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 330. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 332. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 335. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2017-2032 (USD MILLION)
TABLE 336. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 337. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 338. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 340. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 341. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2017-2032 (USD MILLION)
TABLE 342. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 343. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL NEUROSTIMULATION DEVICE MARKET SI

Companies Mentioned

  • Abbott Laboratories
  • Bayer AG
  • Beijing PINS Medical Co.
  • Bioventus Inc.
  • Boston Scientific Corporation
  • Cefaly Technology
  • Curonix LLC.
  • electroCore Inc
  • InCube Labs.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • Motif Neurotech, Inc.
  • Neurosigma, Inc.
  • Nevro Corporation
  • SceneRay Co., Ltd
  • Soterix Medical, Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.64 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Implantable Sacral Neurostimulation Lead Market - Global Forecast 2026-2032 - Product Image

Implantable Sacral Neurostimulation Lead Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Spinal Cord Neurostimulation Implant Market - Global Forecast 2026-2032 - Product Image

Spinal Cord Neurostimulation Implant Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Neurostimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Neurostimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2026-2034 - Product Image

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Neurostimulation Devices Market Forecast to 2033 - Product Image

Neurostimulation Devices Market Forecast to 2033

  • Report
  • 120 Pages
  • Global
From

About the Neurostimulator Market

The Neurostimulator market is a subset of the Neurology Devices market, which includes a variety of medical devices used to diagnose and treat neurological conditions. Neurostimulators are devices that use electrical stimulation to treat neurological disorders, such as chronic pain, epilepsy, and Parkinson's disease. Neurostimulators are typically implanted in the body and can be used to stimulate the brain, spinal cord, or peripheral nerves. Neurostimulators can also be used to treat depression, anxiety, and other mental health conditions. Neurostimulators are typically used in combination with other treatments, such as medications, physical therapy, and lifestyle changes. The market for Neurostimulators is growing, as more people are turning to these devices to treat neurological conditions. Some companies in the Neurostimulator market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.